Reply by Authors
J Urol
.
2019 Nov;202(5):958.
doi: 10.1097/01.JU.0000579312.61159.39.
Epub 2019 Oct 9.
Authors
Michael D Gross
1
,
Art Sedrakyan
2
,
Fernando J Bianco
3
,
Peter R Carroll
4
,
Timothy J Daskivich
5
,
Scott E Eggener
6
,
Behfar Ehdaie
7
,
Benjamin Fisher
8
,
Michael A Gorin
9
,
Bradley Hunt
8
,
Hongying Jiang
8
,
Eric A Klein
10
,
Danica Marinac-Dabic
8
,
Jeffrey S Montgomery
11
,
Thomas J Polascik
12
,
Alan M Priester
13
,
Ardeshir R Rastinehad
14
,
Charles J Viviano
8
,
James S Wysock
15
,
Jim C Hu
1
Affiliations
1
Department of Urology, New York Presbyterian-Weill Cornell Medical College, New York, New York.
2
Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, New York.
3
Urological Research Network, Miami Lakes, Florida.
4
Department of Urology, University of California-San Francisco, San Francisco, California.
5
Division of Urology, Cedars Sinai Medical Center, Los Angeles, California.
6
Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, Illinois.
7
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
8
Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, Maryland.
9
Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
10
Department of Urology, Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
11
Department of Urology, University of Michigan, Michigan.
12
Duke Cancer Institute, Duke Medical Center, Durham, North Carolina.
13
Department of Bioengineering, University of California-Los Angeles, Los Angeles, California.
14
Department of Interventional Radiology, Mount Sinai Health System, New York, New York.
15
Department of Urology, New York University Langone Medical Center, New York, New York.
PMID:
31364932
DOI:
10.1097/01.JU.0000579312.61159.39
No abstract available
Publication types
Comment
MeSH terms
Humans
Male
Patient Selection
Prostatic Neoplasms*
Social Behavior